Tjoapack invests in automated injectables packaging capabilities

Published: 11-Sep-2020
Packaging

The packaging lines are projected to be completed by the end of 2021

Tjoapack is investing in its automated packaging capabilities to meet growing customer demand for pre-filled syringes and vials.

The automated packaging line for vials will start operations in Q1 2021 and will increase its capacity to over 12 million vials per year. Its pre-filled syringes (PFS) capabilities are expected to be operational by Q4 of 2021.

The automated PFS packaging line will have an initial capacity for 7 million syringes per year and will assemble, automate insertion of plunger rods and back-stops, carry out inline labelling and complete coding and vision control.

The investment follows increased demand from existing and new customers for pre-filled and vial packaging in line with the prevalence of chronic diseases that require injectable therapies.

This latest addition to Tjoapack’s service offering follows the recent investment by private equity firm and healthcare specialists, Ampersand Capital Partners.

Dexter Tjoa, CEO at Tjoapack said: “At Tjoapack we’re committed to ensuring we consistently bolster our offering and deliver the efficient and flexible services that our clients expect. The investment from Ampersand allows us to build on our strong foundations, expand our service offering, and ensure we continue to meet customer demand.

Dexter added: “As new therapies emerge to address unmet patient needs for chronic ailments the demand for contract packaging organisation that can handle syringes and vials will continue to rise.

  • Companies:
  • Tjoapack
See more

You may also like

Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

Read more
To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack

Trending Articles

  1. Gerresheimer acquires Bormioli Pharma Group through Blitz LuxCo Sarl merger Gerresheimer and Bormioli Pharma will merge to provide the biotech and pharmaceutical industries with primary packaging solutions, dosing systems, closure solutions and accessories
  2. Primary packaging container considerations for GLP-1-based drugs This article reviews trends related to GLP-1-type pharmaceuticals and discusses considerations for fill-and-finish and primary packaging containers
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Excluding bacterial spores from aseptic compounding Validation of compounding is essential in demonstrating that appropriate controls are in place to maintain asepsis of the process and the sterility of filled products required for patient safety. Cherwell Laboratories’ Andrew Ramage and Andrew Barrow describe how, in collaboration with Great Ormond Street Hospital, a multilayer packaging solution for a bacteriological medium was developed to prevent misleading false results in compounder use validation
  4. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  5. Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
Packaging

Changes ahead as the US FDA proposes longer national drug codes

The national drug code (NDC) is a unique number used by the US Food and Drug Administration (FDA) to identify and report drugs
Packaging

Tjoapack doubles packaging capacity at Netherlands facility

Three production lines have been added, as well as an automated packaging line for vials
Manufacturing

Packaging prefilled syringes: solving the sterility conundrum

What’s the key to ensuring sterility when packaging prefilled syringes?
Packaging

Tjoapack invests $12.1m into Etten-Leur facility

The expansion will see the Tjoapack team almost double with the appointment of more than 100 employees
Packaging

Tjoapack receives investment from Ampersand Capital Partners

Tjoapack has immediate plans to invest in expanding its automated packaging capabilities, including for injectable products, allowing the company to cater to market demand for prefilled syringes and vial packaging
Media

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a number of hurdles and opportunities. A panel of industry experts examine how the slings and arrows of the past twelve months might affect the next ten years
Subscribe now